Analysis of the Digital Pathology Market in China

Emerging Healthcare Reforms Fuel Digital Pathology Growth

Regular Price: USD 4,950

Special Price USD 4,455

10% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 4,455

PAY BY INVOICE

Be the first to review this product

Digital pathology, as a carrier of efficient patient care in the form of long-distance telepathology and telemedecine, can support evolving healthcare needs requiring highly differentiated but integrated products and services. Top causes of inhibited growth is that the costs against the return on investments (ROI) weighs more on the side of costs, while end users’ attitude are no less restrictive. This study predicts that digital pathology will improve in future when new medical applications such as telemedicine as well as new opportunities in the diagnostic services, healthcare IT, and IVD sectors become available.

Table of Contents

Executive SummaryKey FindingsScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsMarket Engineering Measurements (continued)Market Engineering Measurements (continued)Market Engineering Measurements (continued)CEO’s PerspectiveExecutive Summary—Three Big PredictionsMarket OverviewMarket Background─Overview of Healthcare Situation in ChinaMarket Background─China’s Healthcare System Reforms Market Background─Hospital System in ChinaMarket Background─China’s Medical Alliances NetworkMarket Background─Bi-directional Referral SystemEmerging Opportunities for Digital Pathology in Telepathology and TelemedicineApplications of Digital Pathology in ChinaApplications of Digital Pathology in China ExplainedApplications of Digital Pathology in China Explained (continued)Applications of Digital Pathology in China Explained (continued)Digital Pathology Workflow OverviewDigital Pathology Workflow Overview (continued)Overview of Long-distance Telepathology Consultations China’s Consultation and Quality Control Network StructureDigital Pathology Market Segmentation Distribution Channel AnalysisDigital Pathology Hardware Distribution Channel Digital Pathology Hardware Distribution Channel (continued) Competitive PlaybookDigital Pathology Systems Segment OverviewDigital Pathology Services Segment OverviewEvolving Digital Pathology MarketCompetitive EnvironmentKey Market Participants New Market OpportunitiesNew Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued) Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Mega Trend Impact on Digital Pathology IndustryDrivers, Restraints, and Trends—Total Digital Pathology MarketMarket DriversMarket Drivers Explained Market Drivers Explained (continued) Market Drivers Explained (continued) Market Drivers Explained (continued) Market Drivers Explained (continued) Market RestraintsMarket Restraints ExplainedMarket Restraints Explained (continued) Market Restraints Explained (continued) Market Restraints Explained (continued) Forecast and Trends—Total Digital Pathology MarketMarket Engineering MeasurementsForecast AssumptionsTotal Digital Pathology Market—Revenue ForecastTotal Digital Pathology Market—Revenue Forecast DiscussionDigital Pathology Systems Segment BreakdownDigital Pathology Systems Segment—Key FindingsDigital Pathology Systems Segment—Market Engineering MeasurementsDigital Pathology Systems Segment—Market Engineering Measurements (continued)Digital Pathology Systems Segment—Revenue ForecastDigital Pathology Systems Segment—Revenue Forecast DiscussionDigital Pathology Services Segment BreakdownDigital Pathology Services Segment—Key FindingsDigital Pathology Services Segment—Market Engineering MeasurementsDigital Pathology Services Segment—Revenue ForecastDigital Pathology Services Segment—Revenue Forecast DiscussionCustomer and End-user AnalysisDigital Pathology Systems Segment Market OverviewDigital Pathology Customers/End-user SegmentationDigital Pathology Customers/End-user Segmentation (continued)Digital Pathology Customers/End-user Segmentation (continued)Key Companies to WatchCompanies to WatchCompanies to Watch (continued)Strategic RecommendationsStrategic Options and RecommendationsThe Last WordThe Last Word—Three Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)The Last Word—Discussion (continued)Legal DisclaimerAppendixFrost & Sullivan Reference MaterialDecision Support Database─Total Healthcare Expenditure Decision Support Database─Public Healthcare Expenditure Decision Support Database─Private Healthcare Expenditure Decision Support Database─Number of HospitalsMarket Engineering MethodologyLearn More—Next Steps




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Release Date : 31-Oct-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.